Currently out of the existing stock ratings of Bob Hopkins, 14 are a HOLD (24.56%), 42 are a BUY (73.68%), 1 are a SELL (1.75%).

Bob Hopkins

Work Performance Price Targets & Ratings Chart

Analyst Bob Hopkins, currently employed carries an average stock price target met ratio of 67.78% that have a potential upside of 17.18% achieved within 225 days. Previously, Bob Hopkins worked at BAML.

Bob Hopkins’s has documented 120 price targets and ratings displayed on 17 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on SGHT, Sight Sciences at 12-Sep-2023.

Wall Street Analyst Bob Hopkins

Analyst best performing recommendations are on XENT (INTERSECT ENT).
The best stock recommendation documented was for XENT (INTERSECT ENT) at 4/15/2020. The price target of $10 was fulfilled within 2 days with a profit of $0.79 (8.58%) receiving and performance score of 42.89.

Average potential price target upside

of $41.4 (18.83%) on BDX (BECTON DICKINSON AND COMPANY).
of $32.52 (32.29%) on JNJ (JOHNSON & JOHNSON).
of $24.41 (32.42%) on MDT (MEDTRONIC PLC).

ABT Abbott Laboratories AFIB Acutus Medical ISRG Intuitive Surgical JNJ Johnson & Johnson PEN Penumbra SWAV Shockwave Medical LUNG Pulmonx Corp MDT Medtronic PLC OM Outset Medical EW Edwards Lifesciences Corp INSP Inspire Medical Systems BDX Becton Dickinson and Company NARI Inari Medical PRCT Procept Biorobotics Corp SIBN Si-Bone XENT Intersect ENT SGHT Sight Sciences

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Matt Miksic (BARCLAYS)